Division of Basic Medical Research FY2022 List of Projects - Research Program on HIV/AIDS
First Year | Final Year | Principal Investigator | Affiliation | Project Title | |
---|---|---|---|---|---|
FY2020 | FY2022 | AKARI Hirofumi | Kyoto University | Professor | Evaluation in the efficacy of HIV cure therapeutics by the non-human primate model of HIV infection |
FY2020 | FY2022 | TAKAORI Akifumi | Kyoto University | Professor | Development of novel immunotherapy against HIV-1 infection using alpaca VHH technology |
FY2021 | FY2023 | MATANO Tetsuro | National Institute of Infectious Diseases | Director | Study of vaccine development to protect mucosal HIV infection |
FY2021 | FY2023 | TACHIKAWA Ai | National Institute of Infectious Diseases | Division Leader | Study for an immunotherapy towared HIV cure |
FY2021 | FY2023 | OHMORI Tsukasa | Jichi Medical University | Professor | Development of innovative therapies and diagnostic modalities to improve the quality of life of hemophilia as an HIV-related disorder |
FY2021 | FY2023 | TERUYA Katsuji | National Center for Global Health and Medicine | Chief Physician | Study on appropriate management of opportunistic illnesses in the era of early and prolonged ART. |
FY2021 | FY2023 | SATO Kei | The University of Tokyo | Associate Professor | Multiscale investigations of HIV-1/AIDS leading to the elucidation of HIV infection |
FY2021 | FY2023 | YAMAMOTO Takuya | National Institutes of Biomedical Innovation, Health and Nutrition | Project Leader | Developing strategies for the cure of HIV infection based on the immunological analysis of lymphoid tissues |
FY2021 | FY2023 | MASUDA Takao | Tokyo Medical and Dental University | Associate Professor | Elucidation of molecular structure bases for a novel HIV infection mechanism through viral multifunctional molecules. |
FY2021 | FY2023 | YOKOYAMA Masaru | National Institute of Infectious Diseases | Senior Scientist | Elucidation of the structure and function of evolutionary vulnerable sites of HIV-1 envelope glycoprotein and search for drug discovery seeds |
FY2021 | FY2023 | TSUJI Kohei | Tokyo Medical and Dental University | Assistant Professor | Study of novel anti-HIV agents utilizing CD4 mimic compounds |
FY2021 | FY2023 | KUSE Nozomi | National Institute of Infectious Diseases | Senior Research Scientist | Development of a novel approach to enhance cellular immune responses toward a functional cure for HIV-1 |
FY2021 | FY2023 | TAKAHASHI Naofumi | Kumamoto University | Assistant Professor | Establishment and application of HIV-latently infected microglia model |
FY2021 | FY2023 | MOTOZONO Chihiro | Kumamoto University | Lecturer | Identification of human innate-like T cells sensing HIV-1 infected cells |
FY2022 | FY2024 | SAITO Akatsuki | University of Miyazaki | Associate Professor | Dissecting the molecular mechanism of a novel anti-HIV-1 host factor |
FY2022 | FY2024 | KOTANI Osamu | National Institute of Infectious Diseases | Senior Research Scientist | Structural biology and drug discovery of disordered regions in Gag precursor protein Pr55Gag |
FY2022 | FY2024 | KIMURA Kiminori | Tokyo Metropolitan Komagome Hospital | Director | Development of anti-fibrotic agent for liver cirrhosis caused by HIV/HCV co-infection complicated with hemophilia |
FY2022 | FY2024 | KIKUCHI Tadashi | National Institute of Infectious Diseases | Senior Research Scientist | Study of long-term trend of circulating HIV strains and HIV drug resistance in Japan |
FY2022 | FY2024 | NAGATA Naoyoshi | Tokyo Medical University | Associate Professor | Disentangling effects of intestinal immunity through the human gut microbiome on non-AIDS cancers in HIV-infected patients |
FY2022 | FY2024 | SATOU Yorifumi | Kumamoto University | Professor | A development research aiming to elucidate and overcome HIV latency by cutting-edge nucleic acid biotechnology |
FY2022 | FY2024 | CHIKATA Takayuki | Kumamoto University | Lecturer | Study of immunopeptidomics leads to immunotherapy for HIV cure |
FY2022 | FY2024 | MATSUSHITA Shuzo | Kumamoto University | Specially Appointed Professor | Neutralizing antibody-mediated treatment strategy towards cure of HIV-1 infection |
FY2022 | FY2024 | KATSUDA Yousuke | Kumamoto University | Assistant Professor | Establishment of a novel strategy for HIV cure using staple nucleic acid |
Last updated 04/04/22